Strengthening partnerships with patient organizations: insights and opportunities for progress
Ipsen uvedl výsledky globálního průzkumu, kterým chce lépe porozumět spolupráci s pacientskými organizacemi a identifikovat možnosti jejího posílení. Zjištění ukazují pevné, důvěryhodné vztahy a spokojenost s dosavadní spoluprací, avšak s rostoucími očekáváními na dřívější zapojení, transparentnost a sdílení hodnot. Hlavním trendem je posun od zapojení k hlubší ko-kreaci, včetně strategického zapojení do programů, dlouhodobých partnerství a sladění cílů. Ipsen proto bude nadále naslouchat, vyvíjet se a usilovat o spolupráci, která bude pro pacienty skutečně přínosná.
Understanding how partnerships with patient organizations are evolving.
As part of our commitment to communities, Ipsen has completed the global bi-annual survey to better understand how patient organizations experience collaboration with the company, and to identify opportunities to further strengthen these partnerships.
The results provide valuable insights and serve as an important foundation for ongoing listening and continuous improvement.
The survey highlights areas of strength, while also pointing to clear expectations from patient organizations for deeper, more integrated collaboration in the future.
Strong foundations built on trust
Patient organizations generally report positive and well-established relationships with Ipsen, built over time through regular engagement and shared objectives.
Many respondents describe mature partnerships grounded in trust, characterized by consistent interactions and a strong willingness to collaborate.
At the same time, their feedback reinforces the importance of maintaining high standards and continuing to evolve these partnerships to meet changing needs.
“At IKCC, our partnership with Ipsen is rooted in a mutual dedication to elevating the patient voice and fostering shared decision-making within oncology. Ipsen consistently demonstrates a sincere commitment to patient advocacy—whether through training initiatives, publications, collaborative events, or ongoing co-production. These sustained efforts ensure that our work together delivers genuine social impact and is instrumental in creating lasting benefits for patients affected by kidney cancer.“